<DOC>
	<DOCNO>NCT00744380</DOCNO>
	<brief_summary>The purpose randomize , double-blind study evaluate utility , safety , cost transition benzodiazepine sedation dexmedetomidine medical surgical intensive care unit ( ICU ) patient require sedation tracheal extubation near . Fifty medical surgical ICU patient require sedation exist benzodiazepine therapy qualify daily awakening randomize double-blind manner receive additional midazolam dexmedetomidine .</brief_summary>
	<brief_title>Dexmedetomidine Versus Midazolam Facilitating Extubation</brief_title>
	<detailed_description>This study unique midazolam dexmedetomidine add , blinded fashion , exist sedation analgesia effort decrease possibly discontinue therapy . Objectives : The objective study determine transition conventional sedation dexmedetomidine safely facilitate tracheal extubation study initiation ; alters amount sedative analgesic agent require study initiation ; influence level sedation analgesia ; alters adverse event profile ( neurologic , hemodynamic , gastrointestinal ) discontinue sedation ; impact total cost sedation discontinue sedation . Hypothesis 1 : Transitioning conventional sedation dexmedetomidine expedite tracheal extubation shorten ventilator time . Specific Aim 1 : Comparatively determine time study initiation tracheal extubation midazolam dexmedetomidine practice daily awakening use . Hypothesis 2 : Transitioning conventional sedation dexmedetomidine reduce dose conventional sedative analgesic maintain equivalent level sedation analgesia incur adverse event . Specific Aim 2a : Comparatively determine hourly , daily , cumulative dos conventional sedative analgesic study initiation sedation discontinuation midazolam dexmedetomidine practice daily awakening use . Specific Aim 2b : Comparatively evaluate quality sedation analgesia midazolam dexmedetomidine determine proportion Riker sedation score 3 - 4 ( desire level sedation ) ≤ 2 ≥ 5 ( undesired level sedation ) proportion Pain Assessment Behavioral Scores ( PABS ) ≤ 3 ( comfortable ) ≥ 4 ( pain ) . Specific Aim 2c : Comparatively evaluate sedation-related adverse effect ( neurologic , hemodynamic , gastrointestinal ) midazolam dexmedetomidine practice daily awakening use . Hypothesis 3 : Transitioning conventional sedation dexmedetomidine increase cost administer sedation minimizes incidental cost associate sedation counterbalance possibly reduce total cost sedation ( sum administration cost incidental cost ) . Specific Aim 3a : Comparatively determine hourly , daily , cumulative administration cost midazolam dexmedetomidine practice daily awakening use . Specific Aim 3b : Comparatively determine hourly , daily , cumulative incidental cost conventional sedative dexmedetomidine ; include neurologic dysfunction , antipsychotic requirement , cardiovascular dysfunction , constipation ileus , difference time ventilator discontinuation , personnel time , patient transfer ICU sedation discontinuation .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>1 . Patients require mechanical ventilation medical surgical ICUs . 2 . Currently receive lorazepam midazolam continuous infusion purpose sedation therapy . 3 . Sedation ICUs provide use ICUwide order form preferentially use either lorazepam midazolam infusion rate titrate bedside nurse desire Riker sedationagitation score ( ) . Continuous analgesia provide fentanyl infusion rate titrate bedside nurse PABS ≤ 3 . 4 . Anticipated duration continuous sedation &gt; 12 hour level sedation expect maintain Riker sedationagitation score ( ) 3 4 . 5 . Patients qualify daily awakening determine follow : fraction inspire oxygen ( FiO2 ) ≤ 70 % positive end expiratory pressure ( PEEP ) ≤ 14 cmH2O , hemodynamically stable , NOT receive pharmacologic neuromuscular blockade . 6 . Informed consent HIPAA authorization within 24 hour qualify daily awakening . 1 . Patients &lt; 18 year age &gt; 85 year age . 2 . Patients receive intermittent `` need '' administration lorazepam midazolam . 3 . Patients receive lorazepam midazolam purpose sedation ( e.g . seizure control ) . 4 . Patients receive epidural administration medication ( ) . 5 . Patients ChildsPugh class C liver disease . 6 . Comatose patient metabolic neurologic affectation . 7 . Patients active myocardial ischemia second thirddegree heart block . 8 . Moribund state plan withdrawal life support . 9 . Patients know suspect severe adverse reaction midazolam ( benzodiazepine ) dexmedetomidine ( clonidine ) . 10 . Patients alcohol abuse within six month study eligibility . 11 . Pregnant female female suspect pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Analgesia</keyword>
	<keyword>Mechanical ventilation</keyword>
</DOC>